Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate remains among the most important tools in modern anaesthesia and severe pain management across the United Kingdom. As a potent synthetic opioid, its role in the National Health Service (NHS) and personal surgical sectors is well-established, mainly due to its rapid onset of action and cardiovascular stability. This post provides a comprehensive summary of fentanyl citrate injection formulas offered in the UK, their clinical indications, regulative landscape, and administration protocols.
What is Fentanyl Citrate?
Fentanyl citrate is a powerful phenylpiperidine-derivative opioid agonist. It was first manufactured in 1960 and quickly ended up being a cornerstone of perioperative care. In terms of potency, fentanyl is approximately 50 to 100 times more powerful than morphine. Its high lipophilicity enables it to cross the blood-brain barrier quickly, causing an almost instant analgesic result when administered intravenously.
In the UK, fentanyl citrate is primarily utilized by means of the parenteral route (injection) for both sedative and analgesic purposes. It works mostly by binding to the mu-opioid receptors in the main worried system, changing the perception of pain and the emotional reaction to it.
Clinical Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is shown for several specific medical situations:
- Analgesic Action: Used during short operative treatments and in the healing room.
- Analgesic Supplement: Used during the induction and maintenance of inhalation anaesthesia.
- Neuroleptanalgesia: Often utilized in combination with a neuroleptic (such as droperidol) to achieve a state of quiescence and minimized awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
- Pre-medication: To offer sedation and analgesia before the induction of general anaesthesia.
Readily Available Formulations and Strengths in the UK
The UK market provides a number of formulations of fentanyl citrate, designed to meet the varying needs of surgical and emergency situation departments. These are usually provided as clear, colourless solutions for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Common Packaging | Manufacturer Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Pack of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Load of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Load of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU usage) |
Note: While 50 mcg/ml is the basic concentration, specialised formulations for epidural or intrathecal use may often be prepared by medical facility drug stores under particular protocols.
Pharmacokinetics and Pharmacodynamics
Understanding how the body processes fentanyl is essential for safe administration.
- Beginning of Action: When administered intravenously, the result begins practically right away, though the optimum analgesic effect may take 3 to 5 minutes.
- Period: A single intravenous dose of 100 micrograms typically lasts for 30 to 60 minutes.
- Metabolic process: Fentanyl is mostly metabolised in the liver through the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dose is excreted in the urine within 24 hours, primarily as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly managed and typically carried out by anaesthetists or trained practitioners in controlled environments.
Dosage Guidelines
Dose must be horizontal and individualised based upon the patient's age, weight, physical status, underlying pathological condition, use of other drugs, and the type of surgical treatment.
- Low Dose (2 mcg/kg): Useful for minor surgeries.
- Moderate Dose (2-- 20 mcg/kg): Used when surgery is more invasive; needs respiratory tracking.
- High Dose (20-- 50 mcg/kg): Used during "worry-free" major surgeries (e.g., open-heart surgery) to secure the myocardium from the metabolic needs of stress.
Routes of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer procedures or in the ICU.
- Intramuscular (IM): Less common, however used for pre-medication in particular situations.
Regulatory Status and Safety
In the United Kingdom, Fentanyl is categorized under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is categorized as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be saved in a locked controlled drug cupboard.
- Record Keeping: Every administration should be taped in a Controlled Drugs Register (CDR).
- Damage: Surplus or expired fentanyl should be denatured and witnessed by authorised personnel.
Adverse Effects and Adverse Reactions
While extremely reliable, fentanyl citrate carries a threat of significant side results.
- Respiratory Depression: The most major negative effects, which can cause respiratory arrest if not kept track of.
- Bradychardia: Often managed with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation tough, needing making use of neuromuscular blocking representatives.
- Nausea and Vomiting: Common in the postoperative period.
- Hypotension: Although more steady than morphine, it can still occur, specifically in hypovolaemic clients.
Comparison with Other Opioids
Clinicians frequently pick fentanyl over other opioids due to its particular pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Feature | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Beginning | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Period of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Negligible | Substantial | Minimal |
| Primary Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Regularly Asked Questions (FAQ)
1. Is fentanyl citrate injection the like the fentanyl patches?
No. While Fentanyl Citrate Indications UK include the same active drug, the injection is for immediate, severe use in surgical or emergency settings. Patches (transdermal shipment) are created for persistent, long-term discomfort management and launch the medication gradually over 72 hours.
2. Can fentanyl citrate be utilized for kids in the UK?
Yes, it is regularly utilized in paediatric anaesthesia. Nevertheless, the dosage should be strictly determined based upon the child's weight, and they need to be kept an eye on closely for respiratory anxiety.
3. What is Fentanyl Citrate Injection Side Effects UK for fentanyl?
Naloxone is the specific pharmacological antagonist used to reverse the impacts of fentanyl, including breathing anxiety. In UK medical facilities, naloxone should always be easily offered anywhere fentanyl is administered.
4. Why is it used over morphine in heart surgery?
Fentanyl is preferred in heart surgery due to the fact that it does not cause the release of histamine, which can result in vasodilation and hypotension. It supplies cardiovascular stability even at high dosages.
5. What are the storage requirements?
Fentanyl citrate injection ought to be stored listed below 25 ° C and protected from light. As a Schedule 2 drug, it needs to be kept in a lawfully compliant CD cabinet.
Fentanyl citrate injection solutions are important components of the UK's medical toolkit for handling perioperative discomfort and assisting in complex surgical treatments. Its high potency and rapid beginning offer unrivaled accuracy for anaesthetists, offered that rigorous tracking and regulatory standards are maintained. By understanding the different concentrations and the strict procedures surrounding its usage, health care professionals guarantee that this effective medication remains both safe and effective for patients across the country.
Disclaimer: This short article is for informational purposes only and does not make up medical suggestions. Health care experts ought to constantly describe the Summary of Product Characteristics (SmPC) and present BNF standards for the most current recommending information.
